Most Recent Additions*

Link

Extensive cytomegalovirus gastroduodenitis causing gastric outlet obstruction in an immunocompetent patient
Zunaira Jalil, Zubia Zaman, Sundarta Lund, Naresh Kumar Seetlani, and Sidra Arshad

Link

Factors affecting 30-day outcomes in patients undergoing nontraumatic upper extremity amputation: A retrospective descriptive longitudinal study
Warda Ahmed, Asad Saulat Fatimi, Muhammad Hamza, Usama Waqar, Daniyal Ali Khan, Hareem Rauf, Nadia Jivani, and Shahryar Noordin

Link

Utility of instant messaging application, whatsapp, as a tool to augment post-graduate radiology education
Sohail Ahmed Khan, Muhammad Shahid Shamim, Waqas Ahmed Farooqu, Rooha Sultan, Munizha Nisar, Noreen Adnan, Ibrahim Khan, and Hina Andani

Link

Anthropometric and sociodemographic variables, but not preconception or prenatal maternal nutrition supplementation, predict neurodevelopment in offspring of the 'Women First' trial
Stephanie Waldrop, Dhuly Chowdhury, Jamie E. Westcott, Fred Biasini, Ana Garcés, Lester Figueroa, Antoinette Tshefu, Adrien Lokangaka, Melissa Bauserman, and Sarah Saleem

Link

A phase I study of CS-1008 (humanized monoclonal antibody targeting death receptor 5 or DR5), administered weekly to patients with advanced solid tumors or lymphomas
Mansoor Saleh, I. Percent, T. E. Wood, J. Posey III, J. Shah, R. Carlisle, S. Wojtowicz-Praga, and A. Forero-Torres

Link

Non-invasive prenatal testing and the unveiling of an impaired translation process
Blake Murdoch, Vardit Ravitsky, Ubaka Ogbogu, Sarah Ali-Khan, Gabrielle Bertier, Stanislav Birko, Tania M. Bubela, Jeremy De Beer, Charles Dupras, and Meika Ellis

Link

A pilot open-label trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed operable breast cancer
A. Forero-Torres, J. Galleshaw, C. Jones, I. Percent, L. Nabell, J. Carpenter, C. Falkson, H. Krontiras, K. Bland, and Mansoor Saleh

Link

Phase II study of weekly nanoparticle albumin bound (nab)paclitaxel with carboplatin and trastuzumab as 1st-line therapy for HER2-positive metastatic breast cancer (MBC)
A. D. Seidman, A. K. Conlin, A. Bach, A. M. Brufsky, Mansoor Saleh, D. Lake, M. N. Dickler, G. D'Andrea, T. A. Traina, and C. A. Hudis

Link

Non-invasive prenatal testing and the unveiling of an impaired translation process
Blake Murdoch, Vardit Ravitsky, Ubaka Ogbogu, Sarah Ali-Khan, Gabrielle Bertier, Stanislav Birko, Tania M. Bubela, Jeremy De Beer, Charles Dupras, and Meika Ellis

PDF

More haste, less speed: Could public-private partnerships advance cellular immunotherapies?
Tania M. Bubela, Katherine Bonter, Silvy Lachance, Jean-Sébastien Delisle, and E Richard Gol

*Updated as of 07/26/24.